Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

CV6 Therapeutics identifies dUTPase inhibitors

June 18, 2018

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent TLR7 agonists

June 18, 2018

Integrative Research Laboratories Sweden describes modulators of neurotransmission

June 18, 2018

URAT1 inhibitors identified at Atom Bioscience and Pharmaceutical

June 18, 2018

Georgia State University discloses TNF-alpha production inhibitors

June 15, 2018

3D Medicines divulges linifanib prodrugs for cancer

June 15, 2018

ALK inhibitors presented by University of Michigan

June 15, 2018

NeuroVive Pharmaceutical patents protonophores for NAFLD

June 15, 2018

Temple University and Praeventix present 5-HT7 receptor ligands

June 15, 2018

IMPACT Therapeutics identifies WEE1hu inhibitors

June 13, 2018

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...